Nonprofit · EIN 58-2404527
LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN
Tax-exempt · NEW YORK, NY 10011
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2025 | 990 (amended) | $1,283,221 | $1,770,505 | -$487,284 | $3,590,003 | $465,304 | $3,124,699 |
| December 31, 2024 | 990 | $1,755,810 | $1,651,386 | $104,424 | $4,009,793 | $411,086 | $3,598,707 |
| December 31, 2023 | 990 | $1,476,365 | $1,736,198 | -$259,833 | $3,828,174 | $357,401 | $3,470,773 |
Financial details: 990 for the year ended December 31, 2025
Revenue
- Contributions, gifts and grants
- $1,142,651
- of which government grants
- $112,500
- Program service revenue
- $0
- Investment income
- $113,511
- Net gain from sales of assets
- $92,037
- Net income from fundraising events
- $27,059
- Other revenue
- $27,059
Expenses
- Grants and similar amounts paid
- $23,618
- Compensation of officers, directors and key employees
- $460,890
- Other salaries and wages
- $494,303
- Salaries, compensation and benefits (total)
- $1,158,508
- Professional fundraising fees
- $0
- Accounting fees
- $49,830
- Occupancy
- $29,233
- Travel
- $42,085
- Program services (functional)
- $1,442,732
- Management and general (functional)
- $163,581
- Fundraising (functional)
- $164,192
Balance sheet and other
- Total assets, start of year
- $4,009,793
- Total assets, end of year
- $3,590,003
- Total liabilities, end of year
- $465,304
- Net assets, end of year
- $3,124,699
- Net assets without donor restrictions
- $2,425,199
- Net assets with donor restrictions
- $699,500
- Gross receipts
- $4,195,141
- Employees
- 10
- Volunteers
- 6
- Year formed
- 1998
- State of legal domicile
- NY
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2025, highest compensation first.
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| WILLIAM REPICCI | PRESIDENT & CEO Officer | 40 | $314,640 | $57,767 |
| Maria Celia Dupecher | Vice President for Scientific Affairs Highest-paid employee | 40 | $146,250 | $0 |
| JOSEPH DAYAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| Dr Emily Iker | DIRECTOR Trustee or director | 1 | $0 | $0 |
| MELISSA ALDRICH PHD | CHAIRPERSON Trustee or director, Officer | 10 | $0 | $0 |
| RICK PETTY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| Liz Basaca | TREASURER Trustee or director | 1 | $0 | $0 |
| DORON ILAN MD | SECRETARY Trustee or director | 1 | $0 | $0 |
| Jonathan Ross | DIRECTOR Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2024: 7 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| WILLIAM REPICCI | PRESIDENT & CEO Officer | 40 | $299,657 | $48,756 |
| JOSEPH DAYAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DORON ILAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVE MCDOWELL | CHAIRPERSON Trustee or director, Officer | 10 | $0 | $0 |
| RICK PETTY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DEBBIE MILES | TREASURER Trustee or director | 1 | $0 | $0 |
| MELISSA ALDRICH PHD | SECRETARY Trustee or director | 1 | $0 | $0 |
990 for the year ended December 31, 2023: 7 people
| Name | Title | Hours / week | Compensation | Other / benefits |
|---|---|---|---|---|
| WILLIAM REPICCI | PRESIDENT & CEO Officer | 40 | $272,415 | $49,184 |
| JOSEPH DAYAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DORON ILAN MD | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DAVE MCDOWELL | CHAIRPERSON Trustee or director, Officer | 10 | $0 | $0 |
| RICK PETTY | DIRECTOR Trustee or director | 1 | $0 | $0 |
| DEBBIE MILES | TREASURER Institutional trustee | 1 | $0 | $0 |
| MELISSA ALDRICH PHD | SECRETARY Institutional trustee | 1 | $0 | $0 |
Address and contacts
- Address (IRS master file)
- 154 W 14TH STREET, NEW YORK, NY 10011-7307
- In care of
- % WENDY CHAITE
- Principal officer (990 for 2025)
- WILLIAM REPICCI, 154 West 14th Street 2nd Floor, NEW YORK, NY 10011
- Signed the 990
- WILLIAM REPICCI, PRESIDENT & CEO
- Phone
- (516) 625-9675
- Website
- http://lymphaticnetwork.org
- Return prepared by
- CRAIG FITZSIMMONS & MEYER LLP
Mission
THE ORGANIZATION'S MISSION IS TO FIGHT LYMPHATIC DISEASES AND LYMPHEDEMA THROUGH EDUCATION, RESEARCH AND ADVOCACY. THE ORGANIZATION SEEKS TO ACCELERATE THE PREVENTION, TREATMENT, AND CURE OF LYMPHATIC DISEASES WHILE BRINGING PATIENTS AND MEDICAL PROFESSIONALS TOGETHER TO ADDRESS THE UNMET NEEDS SURROUNDING LYMPHATIC DISORDERS.
Program accomplishments
- Some activities of the organization during 2025 include the following: LE&RN continued to expand programs to meet the goals of the expanded mission of fighting lymphatic disease through education, research, and advocacy. LE&RN continued its grant program, which allows young investigators to attend conferences focused on lymphatic research. LE&RN continued its educational and awareness outreach programs targeting academia, government, industry, and the medical and patient communities. LE&RN continued its monthly virtual symposium series, which brings the world's foremost authorities in lymphatic disease and lymphedema to patients, their families, and professionals. LE&RN updated its website and provided daily social media posts and monthly newsletters featuring significant events in the field. LE&RN produced six issues of Lymphatic Research and Biology, an international, peer-reviewedbiomedical journal providing a forum for the exchange of cutting-edge scientific developments in lymphatic science and medicine. LE&RN secured ongoing support from the Congressional and National Institutes of Health for lymphatic research. LE&RN continued the LE&RN/LymphNotes Lymphedema Scholarship Program to provide tuition support to therapists seeking certification in lymphedema therapy. LE&RN continued a web-based "Ask the Experts" feature that allows patients, their families, and professionals to ask the most prominent authorities in the field questions directly. LE&RN spokesperson and Academy Award Winner Kathy Bates appeared in print and television media to support research. LE&RN's Virtual Expo was expanded to better serve patients and therapists. LE&RN and NAVBO prepared a biennial Virtual Lymphatic Forum for researchers LE&RN developed new chapters in several states and countries. LE&RN continued to lead global events related to its establishment of World Lymphedema Day on March 6, 2016. LE&RN supported and grew its Centers of Excellence in the Diagnosis & Treatment of Lymphatic Diseases to 80 member institutions in over 20 countries. LE&RN, in collaboration with Stanford University, hosted the annual virtual State-of-the-Art Summit in Lymphatic Research & Medicine. LE&RN promoted its PSA video featuring National Spokesperson Kathy Bates, which was hosted on the Centers for Disease Control and Prevention (CDC) 's cancer-related websites. LE&RN continued its cancer-related lymphedema campaign. LE&RN succeeded in having the Congressionally Directed Medical Research Program (CDMRP) include lymphedema as a category in the Department of Defense's Peer Reviewed Medical Research Program (PRMRP). LE&RN successfully requested that Congress establish a National Commission on Lymphatic Diseases at the National Institutes of Health (NIH). LE&RN established a global Patient Resource Center. LE&RN expanded and updated its Global Patient Registry. LE&RN successfully advocated for a Program Manager in Lymphatics at the Advanced Research Agency for Health (ARPA-H) LE&RN, in concert with the research community, created a "Gaps in Lymphatic Research" document that was distributed to the NIH, CDC, ARPA-H, CDMRP, NNLBI, and NIAID. LE&RN hired its first full-time Vice President of Scientific Affairs and Science and Medical Director.Expenses $1,442,732 · grants $23,618 · revenue $1,169,710
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | 990 on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 58-2404527
- Tax-exempt status
- 501(c)(3): Charitable, religious, educational or scientific organization
- Foundation status
- Publicly supported organization (170(b)(1)(A)(vi))
- Donations deductible (Pub 78)
- Public charity, 50% deduction limit
- Exempt since
- 1999
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H90)
- Assets (IRS master file)
- $3,590,003
- Income (IRS master file)
- $4,195,141
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2025 | $1,283,221 | $1,770,505 | $3,590,003 | XML |
| 990 | December 2024 | $1,755,810 | $1,651,386 | $4,009,793 | XML |
| 990 | December 2023 | $1,476,365 | $1,736,198 | $3,828,174 | XML |
| 990 | December 2022 | $1,462,533 | $1,490,145 | $3,910,350 | IRS |
| 990 | December 2021 | – | – | – | IRS |
| 990 | December 2020 | – | – | – | IRS |
| 990 | December 2019 | – | – | – | IRS |
| 990 | December 2018 | – | – | – | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 58-2404527).
Questions about LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN
- What is the EIN of LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN?
- The employer identification number (EIN) of LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN is 58-2404527.
- Is LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1999.
- Are donations to LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN tax-deductible?
- Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
- Which annual return does LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN due?
- The return for tax year 2026 (the year ending December 31, 2026) is due May 17, 2027. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2025.
- Who is the principal officer of LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN?
- The 990 for the year ended December 31, 2025 names WILLIAM REPICCI.
- Who are the officers and directors of LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN?
- The 990 for the year ended December 31, 2025 lists 9 people; 2 received compensation from the organization, the highest $314,640 (WILLIAM REPICCI, PRESIDENT & CEO).
- How much revenue does LYMPHATIC EDUCATION & RESEARCH NETWORK INC LE&RN have?
- On its 990 for the year ended December 31, 2025 it reported revenue of $1,283,221, expenses of $1,770,505 and total assets of $3,590,003 at year end.
Other nonprofits in NEW YORK
- MICHAEL J FOX FOUNDATION FOR PARKINSONS RESEARCH EIN 13-4141945 · last filed 990 for 2025
- PUBLIC HEALTH SOLUTIONS EIN 13-5669201 · last filed 990 for 2025
- PARKINSONS FOUNDATION INC EIN 13-1866796 · last filed 990 for 2025
- LICR FUND INC EIN 13-3573053 · last filed 990 for 2024
- CARDIOVASCULAR RESEARCH FOUNDATION EIN 52-1752653 · last filed 990 for 2024
- GLOBAL ALLIANCE FOR TB DRUG DEVELOPMENT INC EIN 13-4128413 · last filed 990 for 2024
- INTERNATIONAL BRAIN RESEARCH ORGANIZATION EIN 88-4372025 · last filed 990 for 2024
- CANCER RESEARCH INSTITUTE INC EIN 13-1837442 · last filed 990 for 2025